Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

DuoGenic StemCells Corporation (7607) Income Statement

DuoGenic StemCells Corporation Income Statement

Last quarter (Q2 2026), DuoGenic StemCells Corporation's total revenue was NT$10.31M, an increase of 102.47% from the same quarter last year. In Q2, DuoGenic StemCells Corporation's net income was NT$-22.39M. See DuoGenic StemCells Corporation’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 20.69MNT$ 12.05MNT$ 13.67MNT$ 6.86MNT$ 2.30M
NT$ 15.79MNT$ 4.10MNT$ 4.90MNT$ -452.00KNT$ -4.98M
NT$ 41.59MNT$ 65.11MNT$ 49.78MNT$ 32.97MNT$ 18.16M
Depreciation and AmortizationNT$ 5.90MNT$ 7.29MNT$ 7.01MNT$ 5.33MNT$ 2.66M
NT$ -19.63MNT$ -53.77MNT$ -37.90MNT$ -28.33MNT$ -20.13M
NT$ -25.79MNT$ -61.01MNT$ -44.88MNT$ -33.42MNT$ -23.14M
NT$ -634.00KNT$ -606.00KNT$ -184.00KNT$ -314.00KNT$ 297.00K
NT$ -26.43MNT$ -61.62MNT$ -45.07MNT$ -33.73MNT$ -22.84M
NT$ -26.38MNT$ -61.58MNT$ -45.24MNT$ -34.05MNT$ -21.98M
Per Share Metrics
Basic EPSNT$ -0.86NT$ -2.01NT$ -1.50NT$ -1.18NT$ -0.86
Diluted EPSNT$ -0.86NT$ -2.01NT$ -1.50NT$ -1.18NT$ -0.86
Weighted Average Shares Outstanding30.85M30.55M30.16M28.80M25.61M
Weighted Average Shares Outstanding (Diluted)30.85M30.55M30.16M28.80M25.61M

Currency in TWD

DuoGenic StemCells Corporation Earnings and Revenue History

-80M-40M040M-1200 %-800 %-400 %0 %EarningsProfit Margin20212022202320242025RevenueEarningsProfit Margin